Johannes De Munter | Chief Executive Officer

Johannes De Munter, Chief Executive Officer, Neuroplast

Johannes P.J.M. de Munter is a trained physician and a registered scenario-epidemiologist with more than 35 years of experience in medical health care. He started as emergency health care physician, general practitioner and specialist infectious diseases, and worked for 15 years as deputy director at the Municipal Department of Public Health and Infectious Disease Control in the southern part of the Netherlands. The last 12 years he was involved in Translational Research and Development and Regulatory Development regarding ATMP’s. He is also (co)author of 8 peer reviewed articles regarding ATMP’s. He is one of the founders of Neuroplast BV and is responsible to develop an autologous stem cell-based product Neuro-Cells to treat various neurodegenerative disorders, including spinal cord injury, parkinsonism and Amyotrophic Lateral Scleroses. Since 2014, Dr de Munter is also employed at the University Maastricht, Department Mental Health and Neuroscience.


Conference Day 1 - Tuesday 31st March 2020 @ 14:40

Industrialized personalized regenerative medicine, promising but very challenging

  • ATMPs in personalized regenerative medicine
  • GMP and remote manufacturing as part of GMP-ATMP and one batch-one patient strategy
  • Safety and autologous stem cell products and regulatory hurdles
last published: 04/Jun/20 08:25 GMT

back to speakers